FCM
ABBV icon

Frontier Capital Management’s AbbVie ABBV Stock Holding History

Frontier Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-54,437
Closed -$3.56M – 363
2014
Q4 		$3.56M Buy
54,437
+1,291
+2% +$81.4K 0.03% 313
2014
Q3 		$3.07M Buy
53,146
+630
+1% +$35K 0.02% 301
2014
Q2 		$2.96M Sell
52,516
-6,570
-11% -$345K 0.02% 298
2014
Q1 		$3.04M Buy
59,086
+2,136
+4% +$108K 0.02% 309
2013
Q4 		$3.01M Sell
56,950
-6,520
-10% -$320K 0.02% 300
2013
Q3 		$2.84M Buy
63,470
+9,500
+18% +$421K 0.02% 309
2013
Q2 		$2.23M Buy
+53,970
New +$2.36M 0.02% 317

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return